Literature search results

361 articles were found.

The following terms were included: 神経膠細胞芽腫, Glioblastom, glioblastoma

• 2018, Anthony P, McArdle S, McHugh M
  Tumor Treating Fields: Adjuvant Treatment for High-grade Gliomas [basics]
  Semin Oncol Nurs 34 (5): 454-464
• 2018, Branter J, Basu S, Smith S
  [details] Tumour treating fields in a combinational therapeutic approach [review]
  Oncotarget 9 (93): 36631-36644
• 2018, Chang E, Patel CB, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS
  Tumor treating fields increases membrane permeability in glioblastoma cells [med./bio.]
  Cell Death Discov 4: 113
• 2018, Karipidis K, Elwood M, Benke G, Sanagou M, Tjong L, Croft RJ
  Mobile phone use and incidence of brain tumour histological types, grading or anatomical location: a population-based ecological study [epidem.]
  BMJ Open 8 (12): e024489
• 2018, Jo Y, Kim EH, Sai S, Kim JS, Cho JM, Kim H, Baek JH, Kim JY, Hwang SG, Yoon M
  Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy [med./bio.]
  Int J Mol Sci 19 (11): E3684
• 2018, Ouadah NS, Lecomte A, Robidel F, Olsson A, Deltour I, Schüz J, Blazy K, Villégier AS
  Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats [med./bio.]
  J Neurooncol 140 (3): 539-546
• 2018, Lei KF, Hsieh SC, Goh A, Kuo RL, Tsang NM
  Proliferation arrest, selectivity, and chemosensitivity enhancement of cancer cells treated by a low-intensity alternating electric field [med./bio.]
  Biomed Microdevices 20 (4): 90
• 2018, Shteingauz A, Porat Y, Voloshin T, Schneiderman RS, Munster M, Zeevi E, Kaynan N, Gotlib K, Giladi M, Kirson ED, Weinberg U, Kinzel A, Palti Y
  AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields) [med./bio.]
  Cell Death Dis 9 (11): 1074
• 2018, Mirza FA, Shamim MS
  [details] Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme [review]
  J Pak Med Assoc 68 (10): 1543-1545
• 2018, Straube C, Oechsner M, Kampfer S, Scharl S, Schmidt-Graf F, Wilkens JJ, Combs SE
  Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas - a planning study [tech./dosim.]
  Radiat Oncol 13: 31
• 2018, Korshoej AR, Hansen FL, Mikic N, von Oettingen G, Sørensen JCH, Thielscher A
  Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations [tech./dosim.]
  PLoS One 13 (8): e0201957
• 2018, Wenger C, Miranda PC, Salvador R, Thielscher A, Bomzon Z, Giladi M, Mrugala MM, Korshoej AR
  [details] A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling [review]
  IEEE Rev Biomed Eng 11: 195-207
• 2018, Narvaez CJ, Mall SK, Fountain A, Parr BA, Chittur SV, Kokorin BI, Botsford SF, Startari JF
  Specifically Targeted Electromagnetic Fields Arrest Proliferation of Glioblastoma Multiforme U-87 Cells in Culture [med./bio.]
  Anticancer Res 38 (6): 3255-3266
• 2018, Amiri M, Basiri M, Eskandary H, Akbarnejad Z, Esmaeeli M, Masoumi-Ardakani Y, Ahmadi-Zeidabadi M
  Cytotoxicity of carboplatin on human glioblastoma cells is reduced by the concomitant exposure to an extremely low-frequency electromagnetic field (50 Hz, 70 G) [med./bio.]
  Electromagn Biol Med 37 (3): 138-145
• 2018, Di Sebastiano AR, Deweyert A, Benoit S, Iredale E, Xu H, de Oliveira C, Wong E, Schmid S, Hebb MO
  Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma [med./bio.]
  Sci Rep 8: 7301
• 2018, Wang D, Wang Z, Zhang L, Li Z, Tian X, Fang J, Lu Q, Zhang X
  Cellular ATP levels are affected by moderate and strong static magnetic fields [med./bio.]
  Bioelectromagnetics 39 (5): 352-360
• 2018, Magouliotis DE, Asprodini EK, Svokos KA, Tasiopoulou VS, Svokos AA, Toms SA
  [details] Tumor-treating fields as a fourth treating modality for glioblastoma: a meta-analysis [review]
  Acta Neurochir 160 (6): 1167-1174
• 2018, Sun YS
  Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study [tech./dosim.]
  Comput Math Methods Med 2018: 3829768
• 2018, Al-Serori H, Ferk F, Kundi M, Bileck A, Gerner C, Mišík M, Nersesyan A, Waldherr M, Murbach M, Lah TT, Herold-Mende C, Collins AR, Knasmüller S
  Mobile phone specific electromagnetic fields induce transient DNA damage and nucleotide excision repair in serum-deprived human glioblastoma cells [med./bio.]
  PLoS One 13 (4): e0193677
• 2018, Benson L
  [details] Tumor Treating Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors [review]
  Semin Oncol Nurs 34 (2): 137-150
• 2018, Li T, Shukla G, Peng C, Lockamy V, Liu H, Shi W
  Dosimetric Impact of a Tumor Treating Fields Device for Glioblastoma Patients Undergoing Simultaneous Radiation Therapy [tech./dosim.]
  Front Oncol 8: 51
• 2018, Philips A, Henshaw DL, Lamburn G, O'Carroll MJ
  Brain tumours: rise in Glioblastoma Multiforme incidence in England 1995–2015 suggests an adverse environmental or lifestyle factor [epidem.]
  J Environ Public Health 2018: 1-10
• 2018, Rick J, Chandra A, Aghi MK
  [details] Tumor treating fields: a new approach to glioblastoma therapy [review]
  J Neurooncol 137 (3): 447-453
• 2018, Yaekashiwa N, Otsuki S, Hayashi S, Kawase K
  Investigation of the non-thermal effects of exposing cells to 70-300 GHz irradiation using a widely tunable source [med./bio.]
  J Radiat Res 59 (2): 116-121
• 2018, Li K, Zhang K, Xu S, Wang X, Zhou Y, Zhou Y, Gao P, Lin J, Ding G, Guo G
  EMP-induced BBB-disruption enhances drug delivery to glioma and increases treatment efficacy in rats [med./bio.]
  Bioelectromagnetics 39 (1): 60-67
• 2018, Carr L, Bardet SM, Arnaud-Cormos D, Leveque P, O'Connor RP
  Visualisation of an nsPEF induced calcium wave using the genetically encoded calcium indicator GCaMP in U87 human glioblastoma cells [med./bio.]
  Bioelectrochemistry 119: 68-75
• 2018, Burri SH, Gondi V, Brown PD, Mehta MP
  [details] The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists [review]
  Am J Clin Oncol 41 (2): 191-196
• 2018, Mun EJ, Babiker HM, Weinberg U, Kirson ED, Von Hoff DD
  Tumor-Treating Fields: A Fourth Modality in Cancer Treatment [basics]
  Clin Cancer Res 24 (2): 266-275
• 2018, Mittal S, Klinger NV, Michelhaugh SK, Barger GR, Pannullo SC, Juhász C
  [details] Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies [review]
  J Neurosurg 128 (2): 414-421
• 2017, Zhu JJ, Demireva P, Kanner AA, Pannullo S, Mehdorn M, Avgeropoulos N, Salmaggi A, Silvani A, Goldlust S, David C, Benouaich-Amiel A, Ram Z
  Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma [med. app.]
  J Neurooncol 135 (3): 545-552
• 2017, Cloughesy TF, Lassman AB
  NovoTTF: where to go from here? [comment]
  Neuro Oncol 19 (5): 605-608
• 2017, Cifuentes-Rius A, Ivask A, Das S, Penya-Auladell N, Fabregas L, Fletcher NL, Houston ZH, Thurecht KJ, Voelcker NH
  Gold Nanocluster-Mediated Cellular Death under Electromagnetic Radiation [med./bio.]
  ACS Appl Mater Interfaces 9 (47): 41159-41167
• 2017, Timmons JJ, Lok E, San P, Bui K, Wong ET
  End-to-end workflow for finite element analysis of tumor treating fields in glioblastomas [tech./dosim.]
  Phys Med Biol 62 (21): 8264-8282
• 2017, Giladi M, Munster M, Schneiderman RS, Voloshin T, Porat Y, Blat R, Zielinska-Chomej K, Hååg P, Bomzon Z, Kirson ED, Weinberg U, Viktorsson K, Lewensohn R, Palti Y
  Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells [med./bio.]
  Radiat Oncol 12: 206
• 2017, Stupp R, Taillibert S, Kanner A, Read W, Steinberg DM, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran DD, Brem S, Hottinger AF, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Burna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z
  Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial [med. app.]
  JAMA 318 (23): 2306-2316
• 2017, Zhu P, Zhu JJ
  [details] Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives [review]
  Chin Clin Oncol 6 (4): 41
• 2017, Mortazavi SMJ, Mortazavi SAR, Paknahad M
  Evaluation of the potential of mobile phone specific electromagnetic fields (UMTS) to produce micronuclei in human glioblastoma cell lines [comment]
  Toxicol In Vitro 44: 414-415
• 2017, Burke RC, Bardet SM, Carr L, Romanenko S, Arnaud-Cormos D, Leveque P, O'Connor RP
  Nanosecond pulsed electric fields depolarize transmembrane potential via voltage-gated K(+), Ca(2+) and TRPM8 channels in U87 glioblastoma cells [med./bio.]
  Biochim Biophys Acta Biomembr 1859 (10): 2040-2050
• 2017, Chang E, Pohling C, Beygui N, Patel CB, Rosenberg J, Ha DH, Gambhir SS
  Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields [med./bio.]
  J Neurooncol 134 (2): 259-268
• 2017, Mrugala MM, Ruzevick J, Zlomanczuk P, Lukas RV
  [details] Tumor Treating Fields in Neuro-Oncological Practice [review]
  Curr Oncol Rep 19 (8): 53
• 2017, Akbarnejad Z, Eskandary H, Dini L, Vergallo C, Nematollahi-Mahani SN, Farsinejad A, Abadi MFS, Ahmadi M
  Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100Hz, 100G) [med./bio.]
  Biomed Pharmacother 92: 254-264
• 2017, Lok E, San P, Hua V, Phung M, Wong ET
  Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma [tech./dosim.]
  Cancer Med 6 (6): 1286-1300
• 2017, Green AL, Mulcahy Levy JM, Vibhakar R, Hemenway M, Madden J, Foreman N, Dorris K
  Tumor treating fields in pediatric high-grade glioma [med. app.]
  Childs Nerv Syst 33 (7): 1043-1045
• 2017, Alegría-Loyola MA, Galnares-Olalde JA, Mercado M
  [Tumors of the central nervous system] [foreign-language]
  Rev Med Inst Mex Seguro Soc 55 (3): 330-340
• 2017, Ulasov IV, Foster H, Butters M, Yoon JG, Ozawa T, Nicolaides T, Figueroa X, Hothi P, Prados M, Butters J, Cobbs C
  Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy [med./bio.]
  J Neurooncol 133 (2): 257-264
• 2017, Carlberg M, Koppel T, Ahonen M, Hardell L
  [details] Case-control study on occupational exposure to extremely low-frequency electromagnetic fields and glioma risk [epidem.]
  Am J Ind Med 60 (5): 494-503
• 2017, Su L, Yimaer A, Wei X, Xu Z, Chen G
  [details] The effects of 50 Hz magnetic field exposure on DNA damage and cellular functions in various neurogenic cells [med./bio.]
  J Radiat Res 58 (4): 474-486
• 2017, Karanam NK, Srinivasan K, Ding L, Sishc B, Saha D, Story MD
  Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines [med./bio.]
  Cell Death Dis 8 (3): e2711
• 2017, Majd P, O'Connell DE, Kim RC, Bota DA, Carrillo JA
  Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma [med. app.]
  CNS Oncol 6 (2): 89-94
• 2017, Clark PA, Gaal JT, Strebe JK, Pasch CA, Deming DA, Kuo JS, Robins HI
  The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells [med./bio.]
  J Clin Neurosci 36: 120-124